Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McGovern

Showing results (161-170 of 275) with videos related to

Pageof 28
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Association of Systemic Sclerosis With a Unique Colonic Microbial ConsortiumElizabeth R Volkmann, Yu-Ling Chang, Nashla Barroso, et al.
Inflammatory Bowel Diseases|October 20, 2015
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel DiseaseMark M Sasaki, Andrew D Skol, Eric A Hungate, et al.
International Journal of Oncology|June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancerRichard E Francis, Stephen S Myatt, Janna Krol, et al.
Scientific Reports|November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathwayChunlan Xu, Sally Ghali, Jiani Wang, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Inflammatory Bowel Diseases|November 22, 2025
Differences in Anti-αvβ6 Integrin Antibody Expression between U.S. and Japanese Cohorts in Inflammatory Bowel DiseaseYoichi Kakuta, Dalin Li, Philip Debbas, et al.
Science Translational Medicine|January 3, 2024
NAD<sup>+</sup> precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunctionAtika Malique, Shengxiang Sun, Kanta Chandwe, et al.
Heliyon|January 29, 2024
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's DiseaseGeorge B McDonald, Ole J B Landsverk, Dermot P B McGovern, et al.
The New England Journal of Medicine|September 25, 2024
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative ColitisBruce E Sands, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|October 26, 2021
A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease RecurrenceMargaret Walshe, Shadi Nayeri, Jiayi Ji, et al.
Pageof 28

Showing results (161-170 of 275) with videos related to

Sort By:
Pageof 28
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Association of Systemic Sclerosis With a Unique Colonic Microbial ConsortiumElizabeth R Volkmann, Yu-Ling Chang, Nashla Barroso, et al.
Inflammatory Bowel Diseases|October 20, 2015
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel DiseaseMark M Sasaki, Andrew D Skol, Eric A Hungate, et al.
International Journal of Oncology|June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancerRichard E Francis, Stephen S Myatt, Janna Krol, et al.
Scientific Reports|November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathwayChunlan Xu, Sally Ghali, Jiani Wang, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Inflammatory Bowel Diseases|November 22, 2025
Differences in Anti-αvβ6 Integrin Antibody Expression between U.S. and Japanese Cohorts in Inflammatory Bowel DiseaseYoichi Kakuta, Dalin Li, Philip Debbas, et al.
Science Translational Medicine|January 3, 2024
NAD<sup>+</sup> precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunctionAtika Malique, Shengxiang Sun, Kanta Chandwe, et al.
Heliyon|January 29, 2024
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's DiseaseGeorge B McDonald, Ole J B Landsverk, Dermot P B McGovern, et al.
The New England Journal of Medicine|September 25, 2024
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative ColitisBruce E Sands, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|October 26, 2021
A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease RecurrenceMargaret Walshe, Shadi Nayeri, Jiayi Ji, et al.
Pageof 28